Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
Gene therapy for ocular rare disease Market Insights, Competitive Landscape and Market Forecast–2026
Gene therapy for ocular rare disease Market Insights, Competitive Landscape and Market Forecast–2026 ‘Gene therapy for ocular rare disease - Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Gene therapy for ocular rare disease and the hi ... Read More
-
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026 Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseas ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2022
“ Anti GM-CSF Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2022
“ Anti-CD33 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032
DelveInsight's "" PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted PCSK9 Inhibitors (PCSK9i) disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
CRISPR Therapies - Epidemiology Forecast - 2032
DelveInsight's "" CRISPR Therapies - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CRISPR Therapies epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geograp ... Read More
-
HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032
DelveInsight's "" HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HER2Negative Metastatic Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More
-
Exosomes - Epidemiology Forecast - 2032
DelveInsight's "" Exosomes - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Exosomes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • T ... Read More
-
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2022
“ T-cell Surface Glycoprotein CD4- Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in T-cell Surface Glycoprotein CD4 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
TrkC receptor antagonists - Pipeline Insight, 2022
“ TrkC receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in TrkC receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
“ Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Anti-CD279 (PD-1) Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022
“ Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Hematopoietic progenitor kinase 1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
“ Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landsca ... Read More
-
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2022
“ Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More
-
Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2022
“ Ubiquitin conjugating enzyme Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Ubiquitin conjugating enzyme Inhibitor development. The report provides detailed coverage of ... Read More
-
WEE1 protein inhibitors - Pipeline Insight, 2022
“ WEE1 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in WEE1 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022
“ Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 8+ pipeline drugs in Protein tyrosine phosphatase non receptor type 11 antagonists pipeline landscape. It covers the pipeline drug profiles, includ ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
DelveInsight's "" Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene and Cell Therapies targeting CNS disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More
-
Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032
DelveInsight's "" Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Guillain-Barre Syndrome (GBS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More
-
Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
DelveInsight’s, “ Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022 ,” report provides an understanding of the current competition, pipeline products, and changing market dynamics of the Liquid Biopsy for Cancer Diagnostics market in the 7 major pharmaceutical ... Read More
-
Dense Deposit Disease - Epidemiology Forecast - 2032
DelveInsight's "" Dense Deposit Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Dense Deposit Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
“ HIV integrase inhibitors - Pipeline Insight, 2021 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in HIV integrase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeut ... Read More
-
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022
“ Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detaile ... Read More
-
Anti-CD152 Antibody - Pipeline Insight, 2022
“ Anti-CD152 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More
-
22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032
DelveInsight's "" 22q11.2 Deletion Syndrome - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted 22q11.2 Deletion Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), ... Read More
Research Assistance
